- Adalimumab 40mg/0.8ml solution for injection vials
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Adalimumab 40mg/0.8ml solution for injection vials | Start Date 15-11-2011 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 0.8
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Caution - AMP level prescribing advised
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L04AB04
- BNF Codes
-
- BNF code 10010300
Code | Start Date | End Date |
---|---|---|
19697711000001100 | 15-11-2011 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Adalimumab | Based on Ingredient Substance | 50 mg | 1 ml |
Name
Adalimumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
1
Parent Products
-
VTMAdalimumab
-
VMP(Current) Adalimumab 40mg/0.8ml solution for i...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 vial | ||
2 vial |